Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors-Reference-Cited by-同舟云学术

Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors

Published:2012-02-13 Issue:4 Volume:55 Page:1465-1477
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Guerrant William¹,Patil Vishal¹,Canzoneri Joshua C.¹,Oyelere Adegboyega K.¹

Affiliation:

1. School of Chemistry and Biochemistry, ‡Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm200799p

Reference71 articles.

1. From magic bullets to designed multiple ligands

2. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

3. Playing dirty

4. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

5. Can we rationally design promiscuous drugs?

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serendipitous discovery of Class I HDAC inhibitors from rational design of molecular glue degraders targeting HDAC;European Journal of Medicinal Chemistry;2024-01

2. Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6;Journal of Medicinal Chemistry;2023-10-02

3. Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis;Arthritis Research & Therapy;2023-09-20

4. Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy;Current Molecular Pharmacology;2023-08-10

5. Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective;Current Medicinal Chemistry;2023-07